Pursuant to Regulation 33 of SEBI (Listing Obligations Disclosure Requirement) Regulations, 2015 Sharon Bio-Medicine has informed that it enclosed the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2021 along with the Limited Review Report issued by E.A Patil & Associates LLP, Statutory Auditors of the Company. The meeting commenced at 12 pm and concluded at 3 pm.
The above information is a part of company’s filings submitted to BSE.